ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: Results from a Phase 3 Study (inMIND)

OR
Please enter your username or email address. You will receive an email message to log in.
Explore more from your favourite experts – click their name to access their entire library of content.

Chair

Speaker
Studies / Trials Discussed
Results from a Phase 3 Study (inMIND)
This program has been made possible through unrestricted support from BeiGene, Eli Lilly & Pfizer
Studies/trials discussed:
Results from a Phase 3 Study (inMIND)
©2025 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement.